602 related articles for article (PubMed ID: 25151981)
1. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
Shi NQ; Qi XR; Xiang B; Zhang Y
J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
[TBL] [Abstract][Full Text] [Related]
2. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
[TBL] [Abstract][Full Text] [Related]
4. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
Kardani K; Milani A; H Shabani S; Bolhassani A
Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
[No Abstract] [Full Text] [Related]
5. Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.
Kalafatovic D; Giralt E
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117144
[TBL] [Abstract][Full Text] [Related]
6. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
Wang F; Wang Y; Zhang X; Zhang W; Guo S; Jin F
J Control Release; 2014 Jan; 174():126-36. PubMed ID: 24291335
[TBL] [Abstract][Full Text] [Related]
7. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
[TBL] [Abstract][Full Text] [Related]
8. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
[TBL] [Abstract][Full Text] [Related]
9. Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges.
Huang YW; Lee HJ; Tolliver LM; Aronstam RS
Biomed Res Int; 2015; 2015():834079. PubMed ID: 25883975
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.
Kristensen M; Nielsen HM
Tissue Barriers; 2016; 4(2):e1178369. PubMed ID: 27358757
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.
Lindberg S; Copolovici DM; Langel U
Ther Deliv; 2011 Jan; 2(1):71-82. PubMed ID: 22833926
[TBL] [Abstract][Full Text] [Related]
12. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells.
Böhmová E; Machová D; Pechar M; Pola R; Venclíková K; Janoušková O; Etrych T
Physiol Res; 2018 Oct; 67(Suppl 2):S267-S279. PubMed ID: 30379549
[TBL] [Abstract][Full Text] [Related]
15. Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery.
Tian Y; Zhou S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1668. PubMed ID: 32929866
[TBL] [Abstract][Full Text] [Related]
16. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
Zhang Q; Gao H; He Q
Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
Bolhassani A; Jafarzade BS; Mardani G
Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
[TBL] [Abstract][Full Text] [Related]
18. In vivo biodistribution and efficacy of peptide mediated delivery.
Järver P; Mäger I; Langel Ü
Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
[TBL] [Abstract][Full Text] [Related]
19. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptides: strategies for anticancer treatment.
Raucher D; Ryu JS
Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
